Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Given Average Rating of “Moderate Buy” by Brokerages
Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Get Free Report) have received an average recommendation of “Moderate Buy” from the seventeen research firms that are presently covering the company, Marketbeat reports. Three analysts have rated the stock with a hold recommendation and fourteen have assigned a buy recommendation to the company. The average twelve-month price […]
More Stories
What is Snapchat Planet Order? Meaning, Origin, and More Details
Snapchat is one of the most widely used social media platforms. It stands neck to neck with other popular social...
Is The Amazing Digital Circus Renewed? Know about its Release Date
Are you also a fan of adult anime shows? Good news, everyone’s favourite fantasy drama, The Amazing Digital Circus, aka...
Tex Mex Motors Season 3 Updates and Renewal Details
The 2023 premiere series, Tex Mex Motors, is a reality TV show. The series has 2 seasons with episodes showing...
Grown Ups 3: Release Date, Cast Members, and Trailer Updates
About 16 years after its release, the comedy film Grown Ups is finally getting a sequel. The famous group of...
Ripe for the Picking Season 2: Release Date, Cast, and More
Ripe for the Picking is a Japanese manga series. It was first released as a magazine before becoming a web...
Lupin Part 4: Release Date, Cast Members, and Trailer
One of the most popular and engaging mystery thriller series, Lupin, is returning for its fourth part. The series was...